India's stock market decline wipes out $1.3 trillion in market value – can investors stay optimistic?
More than $1 trillion has been wiped off from India's stock market after investors turn to China. Has the emerging-market darling hit rock bottom?

India’s “loyal retail traders” are being tested like never before, says Chiranjivi Chakraborty on Bloomberg. A long stock market boom ran into trouble in September, when an unanticipated economic slowdown and analysts’ downgrades to companies’ earnings forecasts knocked India’s richly priced shares – $1.2 trillion has since been wiped off valuations. Global funds withdrew an estimated $26 billion between October and February.
Local investors had kept things ticking along, but even they now appear to be losing enthusiasm, with inflows into domestic mutual funds down 30% since a record high in October. India has been an emerging-market darling in recent years, with the BSE Sensex Index surging 187% between the March 2020 Covid trough and September 2024. Yet, since then, the index has slipped more than 10%.
Many small investors in the Mumbai bourse only got into investing during the Covid-era boom, making this their first market slump, says Veena Venugopal in the Financial Times. Local fund managers are feeling pessimistic, with no immediate “triggers” for a recovery in view and plenty of risk as Donald Trump prepares to unveil new “global tariffs”. “India’s loss is China’s gain.” Global money managers have been distracted by Chinese technology, with Hong Kong’s Hang Seng Tech Index rallying 25% this year amid the DeepSeek mania.
MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
India’s NSE Nifty 50 suffered five straight months of losses through February, its worst losing streak since 1996, says Reuters. Smaller stocks have been especially hard hit, with the Nifty small-cap 100 index dropping 22% from September’s record high.
IT is the latest target, with foreign portfolio investors selling $3.5 billion worth of shares during the first half of March. A large chunk of Indian tech revenue comes from the US, leaving the sector exposed to Trump’s tariff whims.
Has India hit bottom?
By global standards, Indian stocks remain among the world’s priciest, says Craig Mellow in Barron’s. But recent losses arguably constitute a “healthy correction”, with price/earnings (p/e) ratios back to historical averages. State spending “sputtered” after elections last year but shows signs of “picking up again”.
India’s exports are dominated not by goods but by services, which do not attract as much of Trump’s ire. And with a median age of 28 (compared with 38 in China) a demographic dividend is coming through.
Indeed, the BSE Sensex has staged a 6.5% rally since the start of the month, but buying in still requires bravery. “The last shoe to drop will be when retail investors capitulate and sell,” says Arthur Budaghyan of BCA Research. He predicts “at least another 15% drawdown in Indian stocks” before the bottom is in.
This article was first published in MoneyWeek's magazine. Enjoy exclusive early access to news, opinion and analysis from our team of financial experts with a MoneyWeek subscription.
Get the latest financial news, insights and expert analysis from our award-winning MoneyWeek team, to help you understand what really matters when it comes to your finances.
Alex is an investment writer who has been contributing to MoneyWeek since 2015. He has been the magazine’s markets editor since 2019.
Alex has a passion for demystifying the often arcane world of finance for a general readership. While financial media tends to focus compulsively on the latest trend, the best opportunities can lie forgotten elsewhere.
He is especially interested in European equities – where his fluent French helps him to cover the continent’s largest bourse – and emerging markets, where his experience living in Beijing, and conversational Chinese, prove useful.
Hailing from Leeds, he studied Philosophy, Politics and Economics at the University of Oxford. He also holds a Master of Public Health from the University of Manchester.
-
HMRC confirms crypto ETN ISA rules
With crypto ETNs now technically available for UK retail investors, HMRC has confirmed they can be held in an ISA – but there’s a complication
-
Pensioners targeted in fine wine scams – the tactics to watch for
Wine has emerged as the latest lure in investment fraud, with pensioners being specifically targeted by scammers
-
Pierre-Édouard Stérin wants to make France great again
Conservative billionaire Pierre-Édouard Stérin is seeking to lead a political and spiritual renaissance across the Channel. The planning looks meticulous
-
Global investors have overlooked the top innovators in emerging markets
Opinion Carlos Hardenberg, portfolio manager, Mobius Investment Trust, highlights three emerging market stocks where he’d put his money
-
Pinewood Technologies: a drive for growth
Pinewood Technologies’ platform is one of the best in the business. Investors should buy in
-
'EV maker Faraday Future will crash'
Faraday Future Intelligent Electric is failing dismally to live up to its name, says Matthew Partridge
-
Investors should cheer the coming nuclear summer
The US and UK have agreed a groundbreaking deal on nuclear power, and the sector is seeing a surge in interest from around the world. Here's how you can profit
-
8 of the best houses for sale with follies
The best houses for sale with follies in the grounds – from a five-storey Victorian Gothic tower in Tonbridge, Kent, to a former mill in Oxfordshire with gardens that include a folly on an island in a lake
-
A tale of two Reits – why performance matters for valuation
AEW UK and Regional are two Reits that are valued very differently, despite a shared focus on properties outside London
-
Healthcare stocks look cheap, but tread carefully
Shares in healthcare companies could get a shot in the arm if uncertainty over policy in the US wanes, but are they worth the risk?